424 related articles for article (PubMed ID: 31047581)
1. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
Sharma S; Kumar JB; Kim JE; Thordsen J; Dayani P; Ober M; Mahmoud TH
Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
[TBL] [Abstract][Full Text] [Related]
2. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
Szeto SKH; Tsang CW; Mohamed S; Lee GKY; Lok JKH; Hui VWK; Tsang KK; Chen LJ; Brelen M; Lai TYY
Ophthalmologica; 2024; 247(2):118-132. PubMed ID: 38408445
[TBL] [Abstract][Full Text] [Related]
3. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
[TBL] [Abstract][Full Text] [Related]
4. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of submacular hemorrhage: experience at an academic Canadian centre.
Juncal VR; Hanout M; Altomare F; Chow DR; Giavedoni LR; Muni RH; Wong DT; Berger AR
Can J Ophthalmol; 2018 Aug; 53(4):408-414. PubMed ID: 30119797
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy.
Kimura S; Morizane Y; Hosokawa MM; Shiode Y; Doi S; Hosogi M; Fujiwara A; Okanouchi T; Inoue Y; Shiraga F
Jpn J Ophthalmol; 2019 Sep; 63(5):382-388. PubMed ID: 31243593
[TBL] [Abstract][Full Text] [Related]
7. Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique.
Fleissig E; Barak A; Goldstein M; Loewenstein A; Schwartz S
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1341-1347. PubMed ID: 28412773
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
[TBL] [Abstract][Full Text] [Related]
9. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
[TBL] [Abstract][Full Text] [Related]
10. STEP-WISE APPROACH TO THE MANAGEMENT OF SUBMACULAR HEMORRHAGE USING PNEUMATIC DISPLACEMENT AND VITRECTOMY: The Manchester Protocol.
Chew GWM; Ivanova T; Patton N; Dhawahir-Scala F; Jasani KM; Turner G; Charles S; Jalil A
Retina; 2022 Jan; 42(1):11-18. PubMed ID: 34469407
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.
Barayev E; Tiosano A; Zlatkin R; Elul R; Dotan A; Hadayer A; Gal-Or O; Ehrlich R
Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632
[TBL] [Abstract][Full Text] [Related]
12. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
Kimura S; Morizane Y; Hosokawa M; Shiode Y; Kawata T; Doi S; Matoba R; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
[TBL] [Abstract][Full Text] [Related]
13. Flattening of retinal pigment epithelial detachments after pneumatic displacement of submacular hemorrhages secondary to age-related macular degeneration.
Kimura M; Yasukawa T; Shibata Y; Kato A; Hirano Y; Uemura A; Yoshida M; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1823-1829. PubMed ID: 29961921
[TBL] [Abstract][Full Text] [Related]
14. VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR AND GAS TAMPONADE FOR SUBFOVEAL HEMORRHAGE: Prognostic Factors and Clinical Outcomes.
Plemel DJA; Lapere SRJ; Rudnisky CJ; Tennant MTS
Retina; 2019 Jan; 39(1):172-179. PubMed ID: 29135798
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
Treumer F; Roider J; Hillenkamp J
Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
[TBL] [Abstract][Full Text] [Related]
17. Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series.
Patikulsila D; Winaikosol P; Choovuthayakorn J; Watanachai N; Chaikitmongkol V; Kunavisarut P
BMC Ophthalmol; 2022 Oct; 22(1):411. PubMed ID: 36303103
[TBL] [Abstract][Full Text] [Related]
18. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
Tranos P; Tsiropoulos GN; Koronis S; Vakalis A; Asteriadis S; Stavrakas P
Int Ophthalmol; 2021 Dec; 41(12):4037-4046. PubMed ID: 34331185
[TBL] [Abstract][Full Text] [Related]
19. Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator.
Kimura S; Morizane Y; Matoba R; Hosokawa M; Shiode Y; Hirano M; Doi S; Toshima S; Takahashi K; Hosogi M; Fujiwara A; Shiraga F
Jpn J Ophthalmol; 2017 Nov; 61(6):472-478. PubMed ID: 28836011
[TBL] [Abstract][Full Text] [Related]
20. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
Bardak H; Bardak Y; Erçalık Y; Erdem B; Arslan G; Timlioglu S
Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]